Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Dodel

Showing results (101-110 of 250) with videos related to

Pageof 25
Sort By:
Parkinsonism & Related Disorders|February 12, 2011
Health-related quality of life and its determinants in Parkinson's disease: results of an Italian cohort studyYaroslav Winter, Sonja von Campenhausen, Martin Arend, et al.
Stroke|November 13, 2010
Cost of illness in subarachnoid hemorrhage: a German longitudinal studyRichard Dodel, Yaroslav Winter, Florian Ringel, et al.
Journal of Neuroimmunology|March 9, 2010
Midregional Proenkephalin A and N-terminal Protachykinin A are decreased in the cerebrospinal fluid of patients with dementia disorders and acute neuroinflammationAndrea Ernst, Katharina Buerger, Oliver Hartmann, et al.
BMC Geriatrics|February 23, 2020
Clinical and functional patient characteristics predict medical needs in older patients at risk of functional declineAnne-Carina Scharf, Janine Gronewold, Christian Dahlmann, et al.
Journal of Geriatric Psychiatry and Neurology|January 17, 2024
The Care Needs of Patients With Cognitive Impairment in Late-Stage Parkinson's DiseaseJennifer S Pigott, Bastiaan R Bloem, Stefan Lorenzl, et al.
Biomolecules|September 28, 2023
The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson's DiseaseAlexandra Albus, Yannick Kronimus, Monika Burg-Roderfeld, et al.
International Psychogeriatrics|May 29, 2019
Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERASCatherine Reed, Mark Belger, J Scott Andrews, et al.
European Neurology|July 27, 2017
Prevalence, Duration and Severity of Parkinson's Disease in Germany: A Combined Meta-Analysis from Literature Data and Outpatient SamplesDirk Enders, Monika Balzer-Geldsetzer, Oliver Riedel, et al.
Epilepsia|January 5, 2007
Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in GermanyHajo M Hamer, Annika Spottke, Christiane Aletsee, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 29, 2010
Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based studyYaroslav Winter, Yury Bezdolnyy, Elena Katunina, et al.
Pageof 25

Showing results (101-110 of 250) with videos related to

Sort By:
Pageof 25
Parkinsonism & Related Disorders|February 12, 2011
Health-related quality of life and its determinants in Parkinson's disease: results of an Italian cohort studyYaroslav Winter, Sonja von Campenhausen, Martin Arend, et al.
Stroke|November 13, 2010
Cost of illness in subarachnoid hemorrhage: a German longitudinal studyRichard Dodel, Yaroslav Winter, Florian Ringel, et al.
Journal of Neuroimmunology|March 9, 2010
Midregional Proenkephalin A and N-terminal Protachykinin A are decreased in the cerebrospinal fluid of patients with dementia disorders and acute neuroinflammationAndrea Ernst, Katharina Buerger, Oliver Hartmann, et al.
BMC Geriatrics|February 23, 2020
Clinical and functional patient characteristics predict medical needs in older patients at risk of functional declineAnne-Carina Scharf, Janine Gronewold, Christian Dahlmann, et al.
Journal of Geriatric Psychiatry and Neurology|January 17, 2024
The Care Needs of Patients With Cognitive Impairment in Late-Stage Parkinson's DiseaseJennifer S Pigott, Bastiaan R Bloem, Stefan Lorenzl, et al.
Biomolecules|September 28, 2023
The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson's DiseaseAlexandra Albus, Yannick Kronimus, Monika Burg-Roderfeld, et al.
International Psychogeriatrics|May 29, 2019
Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERASCatherine Reed, Mark Belger, J Scott Andrews, et al.
European Neurology|July 27, 2017
Prevalence, Duration and Severity of Parkinson's Disease in Germany: A Combined Meta-Analysis from Literature Data and Outpatient SamplesDirk Enders, Monika Balzer-Geldsetzer, Oliver Riedel, et al.
Epilepsia|January 5, 2007
Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in GermanyHajo M Hamer, Annika Spottke, Christiane Aletsee, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 29, 2010
Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based studyYaroslav Winter, Yury Bezdolnyy, Elena Katunina, et al.
Pageof 25